XML 28 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900

Current Accrued Liabilities

12 Months Ended

Dec. 31, 2015

Disclosure Component Of Current Accrued Liabilities [Abstract]

Current Accrued Liabilities

6. Current Accrued Liabilities

Current accrued liabilities consist of the following (in thousands):

	December 31,
	2015				2014
Payroll and related expenses	$	5,866			$	4,613
Legal expenses		202				224
Third party research expenses		5,241				5,898
Third party development expenses		2,072				1,000
Return of funding due to AstraZeneca AB (“AstraZeneca”) (Note 9)		7,345			-
Other accrued liabilities		1,972				1,520
Total	$	22,698			$	13,255

X

- Definition

Disclosure component of current accrued liabilities.

+ References

No definition available.

+ Details

Name:	dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract
Namespace Prefix:	dvax_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.

+ References

No definition available.

+ Details

Name:	us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration